Q2 2022 Holdings
Filed 2022-08-15 | 82 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $216.9M | 572,500 | 19.9% |
| Avantor Inc(AVTR) | COM | 05352A100 | $206.9M | 6,652,700 | 18.9% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $141.2M | 3,355,623 | 12.9% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $115.6M | 755,000 | 10.6% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $94.1M | 2,525,000 | 8.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $89.8M | 440,566 | 8.2% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $70.0M | 1,035,000 | 6.4% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $50.7M | 1,438,999 | 4.6% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $34.9M | 2,981,000 | 3.2% |
| ARK ETF TR(ARKG) | GENOMIC REV ETF | 00214Q302 | $23.6M | 750,000 | 2.2% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $16.0M | 2,950,000 | 1.5% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $11.2M | 1,715,000 | 1.0% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $7.3M | 865,000 | 0.7% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $5.3M | 688,330 | 0.5% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $5.3M | 2,000,000 | 0.5% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $231.2K | 3,499,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $223.5K | 793,000 | 0.0% |
| Elevance Health Inc(ELV) | COM | 036752103 | $212.8K | 441,000 | 0.0% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $197.8K | 610,000 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $193.0K | 412,300 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $171.0K | 725,600 | 0.0% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $159.8K | 900,200 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $148.1K | 1,856,900 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $143.1K | 1,467,600 | 0.0% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $139.3K | 1,875,000 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $126.8K | 388,800 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $124.4K | 242,200 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $104.9K | 5,450,000 | 0.0% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $102.5K | 955,000 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $100.8K | 3,585,881 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $97.3K | 550,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $88.3K | 1,479,500 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $58.2K | 1,125,194 | 0.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $55.0K | 1,000,000 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $50.4K | 1,350,000 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $48.5K | 1,369,100 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $44.3K | 775,504 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $41.0K | 2,972,947 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $39.4K | 4,265,000 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $33.5K | 4,050,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $30.2K | 2,080,200 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $25.9K | 204,570 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $25.8K | 1,325,000 | 0.0% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $19.3K | 758,211 | 0.0% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $17.4K | 1,414,082 | 0.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $16.2K | 1,919,800 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $15.8K | 1,200,000 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $15.7K | 4,855,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $15.4K | 1,392,300 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $13.7K | 450,000 | 0.0% |